Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divalent and heavy metal ions represent a diverse group of chemical entities that serve as the primary targets for chelation therapy in cases of acute or chronic poisoning (NIH: Heavy Metal Toxicity). These ions include essential elements like copper and iron, which can become toxic in overload states, as well as non-essential toxic metals such as lead, mercury, and cadmium (StatPearls: Chelation Therapy). In biological systems, these ions often exert toxicity by binding to sulfhydryl groups on proteins, displacing essential metal cofactors from enzymes, or inducing oxidative stress through the Fenton reaction (PubMed: Metal Toxicity Mechanisms). Therapeutic agents, known as chelators, interact with these ions by forming stable, multi-dentate coordination complexes that neutralize the metal's reactivity and enhance its renal or biliary clearance (PubChem: Chelating Agents). Targeting these ions is critical in managing conditions like Wilson's disease, hemochromatosis, and environmental lead exposure. However, pharmacological intervention must be carefully managed to avoid the depletion of essential divalent cations like calcium and zinc, which are vital for normal physiological function.
Chelating agents act as polydentate ligands that form stable, ring-like coordination complexes with divalent and heavy metal ions, effectively sequestering them from biological ligands and facilitating their excretion from the body (StatPearls: Chelation Therapy).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divalent and heavy metal ions.